Renaissance Funding Administration, an funding administration firm, launched its Q2 2025 “Giant Cap Development Technique” investor letter. A duplicate of the letter could be downloaded right here. The inventory market skilled vital volatility within the second quarter, and but, the S&P 500 posted an all-time excessive by the tip of June. The liberation day tariff announcement set off havoc available in the market, inflicting inventory costs to drop 7% from April 2 to April 7. Nonetheless, the market rebounded and gained greater than 22% from the April 7 low by means of the tip of June. The Russell 1000 Development returned 17.8% and the S&P 500 returned 10.9% within the quarter. Giant caps considerably outperformed their small-cap counterparts, and progress outperformed worth. In opposition to this backdrop, the technique outperformed the S&P 500 Index however underperformed the Russell 1000 Development benchmark. For extra info on the fund’s greatest picks in 2025, please examine its prime 5 holdings.
In its second-quarter 2025 investor letter, Renaissance Giant Cap Development Technique highlighted shares corresponding to Thermo Fisher Scientific Inc. (NYSE:TMO). Thermo Fisher Scientific Inc. (NYSE:TMO) provides life sciences options, analytical devices, specialty diagnostics, laboratory merchandise, and biopharma providers. The one-month return of Thermo Fisher Scientific Inc. (NYSE:TMO) was -0.11%, and its shares misplaced 21.70% of their worth during the last 52 weeks. On September 09, 2025, Thermo Fisher Scientific Inc. (NYSE:TMO) inventory closed at $487.65 per share, with a market capitalization of $182.859 billion.
Renaissance Giant Cap Development Technique acknowledged the next relating to Thermo Fisher Scientific Inc. (NYSE:TMO) in its second quarter 2025 investor letter:
“Thermo Fisher Scientific Inc. (NYSE:TMO) was one other underperformer, declining 18.5% regardless of reporting stable working outcomes. As well as, the corporate lowered full-year steering on tariff-related macro weak point and launched uncertainty associated to Nationwide Institute of Well being (NIH) funding delays which have negatively impacted its educational and authorities clients.
